What Is uniQure N.V. (QURE) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, uniQure N.V.'s intrinsic value is estimated at $8.93, suggesting the stock is overvalued at its current price of $41.52. With 10 out of 11 models flagging downside (-78.5% average return), the market may be pricing in unsustainable growth. Model dispersion is worth noting: PWERM targets $47.13 (+13.5%), versus Dynamic NAV at $0.32 (-99.2%). This +112.7% range highlights the importance of multi-model analysis rather than relying on any single methodology.
What Do the Models Say About QURE?
11 of 13 models are currently active for QURE. Of these, 1 model suggests upside while 10 models suggest overvaluation. The Bayesian DCF estimates QURE's intrinsic value at $9.75, implying -76.5% downside from the current price. See which stocks rank higher →
How Does QURE Rank in Pharmaceutical Preparations?
Among 469 Pharmaceutical Preparations stocks, QURE ranks #57 by Quality of Company score. CirclFi's QOC score of 7.2/10 evaluates 32 fundamental signals. A score of 7.2 indicates above-average quality.
See all Most Undervalued Pharmaceutical Preparations Stocks →
As a biopharma enterprise, uniQure N.V. operates in a sector where R&D productivity ratio is a critical driver of valuation. Investors evaluating QURE should weigh these sector-specific dynamics alongside our model-derived fair values.
Is QURE a Value Trap?
CirclFi's Value Trap algorithm assigns QURE a score of 26/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
11 of 13 models are active for uniQure N.V.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi 32-factor quality framework, uniQure N.V.'s fundamental quality profile registers 7.2/10. This respectable score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.
The gap between the most bullish and bearish model spans +112.7% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every QURE valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across QURE's 11 active models, average confidence is 21%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad